What’s Jefferies’s Current Rate of Aurora Cannabis Inc (ACB)

On Monday morning, a coverage has started with Aurora Cannabis Inc (ACB) that has Buy rating at Jefferies, Octafinance.com reports.

Ticker’s shares touched $7.62 during the last trading session after 4.52% change.Aurora Cannabis Inc. is uptrending after having risen 14.37% since February 26, 2018. ACB has 29.65 million volume or 51.34% up from normal. ACB outperformed the S&P500 by 14.37%.

Aurora Cannabis Inc. produces and distributes medical cannabis products.The firm is valued at $7.57 billion. It is vertically integrated and horizontally diversified across various divisions of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.The P/E ratio is 35.27. The company's products consist of dried cannabis and cannabis oil; CanniMed vegan capsules; and hemp products, as well as sells vaporizers, consumable vaporizer accessories, and herb mills for using herbal cannabis products.

For more Aurora Cannabis Inc. (NYSE:ACB) news posted recently go to: Benzinga.com, Midasletter.com, Fool.com, Nasdaq.com or Fool.com. The titles are as follows: “Aurora Cannabis (NYSE:ACB) Issues Below-Consensus Q2 Revenue Guidance – Benzinga” posted on January 08, 2019, “High Tide Inc (CNSX:HITI) Cannabis Accessory Retailer Backed by Aurora Cannabis (TSE:ACB) – Midas Letter” on February 22, 2019, “Marijuana Stock CannTrust Officially Moves to the NYSE — Is It a Buy? – Motley Fool” with a publish date: February 25, 2019, “Should You Buy Cronos Group Stock Right Now? – Nasdaq” and the last “Big Marijuana Is Booming — Except for 1 Stock – Motley Fool” with publication date: January 28, 2019.